RGT 0.00% 32.0¢ argent biopharma limited

Ann: FDA Approval Granted and First US Distribution Deal Signed-MXC.AX, page-175

  1. 200 Posts.
    lightbulb Created with Sketch. 34
    Cbyrne11, as a clinical pharmacist, I can tell you that naturally-derived/plant-based medicines are able to largely by-pass the 'research+design' phase of 10-20 years because of regulatory loopholes. Furthermore, even if what you said was true, a superfluous amount of evidence already exists for its use in a myriad of conditions such as pain and epilepsy, albeit, they are the results of studies found in research performed by other countries - this does not discount the fact that their clinical trials are indeed valid for use regarding TGA's decisions; much the contrary as this allows a meta-analysis of randomised-controlled trials to be performed, which is, the GOLD STANDARD when it comes to releasing a new drug on the market. I can also tell you that the evidence for medicinal cannabis is overwhelming and it is only a matter of time before it becomes the next 'penicillin'.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
0.000(0.00%)
Mkt cap ! $15.48M
Open High Low Value Volume
30.0¢ 32.0¢ 30.0¢ $31.45K 98.95K

Buyers (Bids)

No. Vol. Price($)
1 4674 30.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 4326 1
View Market Depth
Last trade - 12.44pm 05/09/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.